3D Imaging Drug Design and Development — FDA Facility Profile

FEI 3009143510

3D Imaging Drug Design and Development is an FDA-registered facility (FEI 3009143510) located in Little Rock, AR, US. Registered operations: POSITRON EMISSION TOMOGRAPHY DRUG PRODUCTION. RegDataLab tracks 3 FDA inspections and 1 compliance action at this facility.

Facility Details

Location
Little Rock, AR (US)
Registration Expires
December 31, 2026
Operations
POSITRON EMISSION TOMOGRAPHY DRUG PRODUCTION
Source
decrs